Colorectal Cancer Clinical Trials in Chicago

Showing 141-160 of 177 trials

Partial Wave Spectroscopic Detection of Colon Cancer Risk

NCT01095432

The purpose of this study is to study samples of rectal mucosa (the moist lining of the rectum) using a new light scattering technology, called partial wave spectroscopy (PWS) in patients who will undergo a standard of care colonoscopy or a flexible sigmoidoscopy and have a history of ulcerative colitis (UC).

Ulcerative ColitisColon Cancer

University of Chicago40 participantsStarted Mar 2010

Chicago, Illinois, United States

COMPLETED2.2 miles

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

NCT01397747

The primary objective is to determine the sensitivity and specificity of the Exact Colorectal Cancer (CRC) screening test for colorectal cancer, using colonoscopy as the reference method. Lesions will be confirmed as malignant by histopathologic examination. The secondary objective is to compare the performance of the Exact CRC screening test to a commercially available FIT assay, both with respect to cancer and advanced adenoma. Lesions will be confirmed as malignant or precancerous by colonoscopy and histopathologic examination.

Colorectal NeoplasmsDigestive System DiseasesColonic Diseases+1 more

Exact Sciences Corporation12,776 participantsStarted Jun 2011

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +181 more locations

Partial Wave Spectroscopic Detection of Colon Cancer Risk

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Colorectal Cancer Trials in Other Cities

Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Other Conditions in Chicago